"Anti-fat" drug could be available within four years

An "anti-fat" drug with a significant worldwide market potential could be available in four years, after tests on obese men showed encouraging results, according to the Australian pharmaceutical research company developing the drug.<BR />

Published By MarketLine

"E-events" becoming increasingly important for pharmaceutical product promotion

Published By MarketLine

"Exercise pill" could trick body into burning fat

Scientists have developed a drug that enables mice to burn fat even when they are not exercising, making them resistant to a high-fat diet.

Published By MarketLine

$1.1 million grant awarded to University of Chicago School of Medicine for study of squalamine in prostate

The US Department of Defense, Army Medical Research and Materiel Command has awarded the University of Chicago School of Medicine a $1.1 million grant for the first clinical trial of squalamine in the treatment of prostate cancer.

Published By MarketLine

$10m awarded to AIDS and cancer researcher in lawsuit

Published By MarketLine

$12 million SPORE grant spurs head and neck cancer research

The University of Texas M D Anderson Cancer Center has been awarded its fifth SPORE grant from the National Cancer Institute, a $12 million grant for head and neck cancer research.

Published By MarketLine

$168 Million In US Rituxan Sales Announced By IDEC Pharmaceuticals for the First Quarter, 2001

Published By MarketLine

$18 million in funding for center for deadly diseases

A National Institutes of Health body has set aside funding worth $18 million to establish a computer database designed to identify and exploit the weak spots in a number of deadly microorganisms.

Published By MarketLine

$90 million fine for illegal Internet prescriptions

The State Board of Pharmacy for California has fined a Los Angeles pharmacy and two of its doctors $90 million after an investigation discovered over 3,500 illegal prescriptions that had been provided to customers purchasing drugs via the Internet.

Published By MarketLine

'Bat Saliva' trials give hope to stroke sufferers

Clinical trials conducted by Paion GmbH have demonstrated that a protein from bat saliva could offer a new treatment for strokes or brain attacks. Patients in the phase II study were treated with Desmoteplase, a genetically engineered version of a blood clot-dissolving protein found in the saliva of vampire bats.

Published By MarketLine